Guide: Accelerate your weight loss drug discovery
A new Guide is now available from Eurofins Discovery entitled ‘Drug Discovery for Anti-Obesity‘.
- Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions.
- Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools.
- Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss therapeutics.